FP7 logo euThe SATURN project has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement n°241796

Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria

Partners: Eberhard Karls Universitaet Tuebingen - (EKUT)

The organisation

Research is one of the basic mandates of the University Hospital Tübingen in addition to patient care and medical education. Concentration on excellent research focus areas ensures that the Faculty of Medicine maintains a preeminent position in national and international rankings. EKUT includes 17 hospitals with 1,500 beds and almost 62,000 hospitalisations per year. The Division of Infectious Diseases (Prof. Tacconelli) and Microbiology (Prof. Autenrieth) have been involved in numerous international and national multicentre clinical trials. Prof. Tacconelli has already coordinated the trial at UCSC and will now coordinate the final data analysis and publication from his new position.

Key staff involved in the project

Evelina TacconelliEvelina Tacconelli (MD, PhD), Professor of Infectious Diseases and Head of the Division of Infectious Diseases at the Tübingen University since October 2012. Previously Assistant Professor of Infectious Diseases at the UCSC until October 2012, and Lecturer on Médicine at the Beth Israel Deaconess Medical Centre and Harvard Medical School, USA. She received the research excellence award from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), is the ESCMID Professional Affair Officer for Infectious Diseases, and serves on the editorial board of Lancet Infectious Diseases, Journal of Antimicrobial Chemotherapy, and Clinical Microbiology and Infection. She has published over 100 original articles in peer-reviewed journals. She has participated in EU-funded projects on clinical and microbiological aspects of healthcare associated infections (TREAT, AIDA, SATURN, Implement), and coordinated a research group focused on epidemiological and clinical aspects of multidrug-resistant infections.

Ingo Autenrieth (MD, PhD), Professor and chair of the Institute of Medical Microbiology and Hygiene, chair of the Interfaculty Institute of Microbiology and Infection Medicine, and Dean of the Medical Faculty. Among his major research interests are the microbe-host-interactions, including Candida.

Top ^